RxDoctor Payments DataLook up a doctor →

Arjun Balar

Medical Oncology · New York, NYNPI 1558528273

Payments from drug & device makers

$6,131,846in general payments, 2019–2025

Across 726 payments — averaging $8446.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$3.9M
  • Seagen Inc.$1.4M
  • Genentech, Inc.$309K
  • AbbVie$180K
  • E.r. Squibb & Sons, L.L.C.$166K
  • AstraZeneca$59K
  • plus $168K from 14 others

What the payments were for

  • Consulting fees$119,25380%
  • Speaking & faculty fees$12,7949%
  • Travel & lodging$14,72810%
  • Food & beverage$2,1411%
  • Education$110%

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,131,846 in reported general payments places this provider in the 85th percentile of 498 medical oncology providers in New York.

See all medical oncology providers in New York

Other medical oncology in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →